Abstract
A 83-year-old man was admitted to our hospital for the treatment of advanced ascending colon cancer with liver metastases. He had initially undergone an ileocecal resection for ascending colon cancer. Subsequently, we started oral administration of UFT/LV (UFT 400 mg/day, LV 75 mg/day, and 4 weeks of therapy followed by a week suspension of treatment). After 3 courses, his tumors responded well to treatment, and CT showed marked regression of liver metastases. After 10 courses, liver metastases had almost disappeared. Two years passed without any adverse events since UFT/LV therapy was started. These findings suggest that UFT/LV therapy is very safe and effective for elderly patients with unresectable colorectal cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 473-475 |
| Number of pages | 3 |
| Journal | Japanese Journal of Cancer and Chemotherapy |
| Volume | 39 |
| Issue number | 3 |
| Publication status | Published - Mar 2012 |
| Externally published | Yes |
Keywords
- Colorectal cancer
- Liver metastases
- UFT/Leucovorin
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Marked response to oral administration of UFT and leucovorin for liver metastases from colon cancer in an elderly patient'. Together they form a unique fingerprint.
Cite this
Teraishi, F., Ozaki, K., Shibuya, Y., Shima, Y., Nakamura, T., Hamada, M., Fukui, Y., Nishioka, Y., Horimi, T., & Uchida, Y. (2012). Marked response to oral administration of UFT and leucovorin for liver metastases from colon cancer in an elderly patient. Japanese Journal of Cancer and Chemotherapy, 39(3), 473-475.